3 August 2015Insurance

A firm hand on innovation

The unpredictability of the pharmaceutical and life sciences sector, given its infrequent nature and reliance on innovation, can result in devastating claims for insurers. However, insurers must continue to strive to smooth out the volatility and make these risks more stable.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

US E&S lines offer key growth opportunity for London Market: AM Best

31 March 2026 Excess & surplus seen as sustaining growth, despite pricing pressure in core lines.

E&S casualty trends scatter, risks on wheels still toughest to place

31 March 2026 Excess auto capacity still contracting; agriculture won’t recoup lost capacity fast.

Korean broker launches first MGA to be operated out of Korean market

31 March 2026 Pioneer move gets Lloyd’s coverholder status, focuses on healthcare liability.

More articles

Hail Mary: hailstorms account for 80% of all storm losses

US E&S lines offer key growth opportunity for London Market: AM Best

E&S casualty trends scatter, risks on wheels still toughest to place

Korean broker launches first MGA to be operated out of Korean market

Lotus Re and Gibraltar Re name Bermuda reinsurance President

Howden Re ramps up Spain volcanic risk modelling with Mitiga Solutions

MSIG Hong Kong shakeup finds new deputy CEO

Gen Re elevates CFO to executive board

Copyright © intelligentinsurer.com 2024 | Headless Content Management with Blaze